HIV and AIDS Trial, Recruiting (NCT06367348)

HIV and AIDS Trial, Recruiting NCT06367348 Sponsor: University of California, San Francisco Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06367348 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The person must be in a married or live-in relationship with a partner.
At least one person in the couple must have screened positive for harmful alcohol use in the past 3 months.
At least one person in the couple must have been on HIV treatment (antiretroviral therapy) for at least 6 months.
The HIV-positive person in the couple must have already told their partner about their HIV status.

Who may not be able to join:

Couples where serious physical or emotional abuse between partners has occurred in the past 3 months, or where either person feels their safety could be put at risk by taking part in the study.
Couples who already took part in an earlier pilot study called the Mlambe pilot study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amy Conroy, PhD, University of California, San Francisco

Phone: +265 8883 70081

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06367348

Sponsor: University of California, San Francisco

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: +265 8883 70081

More information: https://clinicaltrials.gov/study/NCT06367348

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The person must be in a married or live-in relationship with a partner.
At least one person in the couple must have screened positive for harmful alcohol use in the past 3 months.
At least one person in the couple must have been on HIV treatment (antiretroviral therapy) for at least 6 months.
The HIV-positive person in the couple must have already told their partner about their HIV status.

Who may not be able to join:

Couples where serious physical or emotional abuse between partners has occurred in the past 3 months, or where either person feels their safety could be put at risk by taking part in the study.
Couples who already took part in an earlier pilot study called the Mlambe pilot study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, San Francisco

Registry

ClinicalTrials.gov

Start date

14 February 2025

Est. completion

1 May 2028

Where this trial is recruiting

Malawi

Primary endpoints

Unhealthy alcohol use measured using the Alcohol Use Disorders Identification Test (AUDIT-C) and/or the Phosphatidylethanol test; Unhealthy alcohol use measured using the Alcohol Use Disorders Identification Test (AUDIT-C) and/or the Phosphatidylethanol test; Unhealthy alcohol use measured using the Alcohol Use Disorders Identification Test (AUDIT-C) and/or the Phosphatidylethanol test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov